0001437749-12-005463.txt : 20120524 0001437749-12-005463.hdr.sgml : 20120524 20120524152210 ACCESSION NUMBER: 0001437749-12-005463 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120523 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20120524 DATE AS OF CHANGE: 20120524 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HELIX BIOMEDIX INC CENTRAL INDEX KEY: 0000831749 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 912099117 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 033-20897 FILM NUMBER: 12867088 BUSINESS ADDRESS: STREET 1: 22118 20TH AVE SE STREET 2: SUITE 204 CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 425 402 8400 MAIL ADDRESS: STREET 1: 22118 20TH AVE SE STREET 2: SUITE 204 CITY: BOTHELL STATE: WA ZIP: 98021 FORMER COMPANY: FORMER CONFORMED NAME: CARTEL ACQUISITIONS INC DATE OF NAME CHANGE: 19890718 FORMER COMPANY: FORMER CONFORMED NAME: CARIBBEAN ACQUISTIONS INC DATE OF NAME CHANGE: 19880725 8-K 1 helix_8k-052312.htm FORM 8-K helix_8k-052312.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): May 23, 2012

 
HELIX BIOMEDIX, INC.
(Exact name of registrant as specified in its charter)
 
 
DELAWARE
033-20897-D
91-2099117
(State or other jurisdiction
of incorporation or organization)
(Commission
File Number)
(IRS Employer
Identification No.)
 
22118 20th Avenue S.E., Suite 204
Bothell, Washington 98021
(425) 402-8400
 
(Address and telephone number of registrant’s principal executive offices)

 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):
 
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 
 
Item 5.07  Submission of Matters to a Vote of Security Holders.

The 2012 Annual Meeting of the Stockholders of Helix BioMedix, Inc. (the “Company”) was held on May 23, 2012, at which the following matters were approved as follows:

1.
  
The election of the following Class III directors to serve until the 2015 Annual Meeting of Stockholders or until each such director’s successor is elected and qualified:
 
Nominee
     For
     
 Withheld  
Broker Non-Votes
  
R. Stephen Beatty
  
33,143,658
  
275,270
  
     6,996,500
  
John F. Clifford
  
33,208,734
  
210,194
  
     6,996,500
  
Lawrence Blake Jones
  
33,295,958
  
122,970
  
     6,996,500
  
 
2.
  
The ratification of the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2012:

For
  
  Against
  
  Abstain
  
Broker Non-Votes
  
        40,054,127
  
  348,039
  
  13,262
     0
 

 These are the final voting results.
 
 
2
 
 

SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
         
     
HELIX BIOMEDIX, INC.
       
Dated: May 24, 2012
  
By:
 /s/ R. Stephen Beatty
       
R. Stephen Beatty
       
President and Chief Executive Officer